Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SPYK 04

Next Previous
Drug Profile

SPYK 04

Alternative Names: SPYK-04

Latest Information Update: 14 Aug 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Chugai Pharmaceutical
  • Class Antineoplastics; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Solid tumours

Most Recent Events

  • 18 Jun 2026 Chugai Pharmaceutical completes phase I clinical trials in Solid tumours (Metastatic disease, Inoperable/Unresectable, Second-line therapy or greater, Recurrent, Monotherapy) in Japan and USA (PO) (NCT04511845)
  • 30 May 2025 Efficacy and adverse events data from phase I trial in Solid tumours presented at the 61st Annual Meeting of the American Society of Clinical Oncology (ASCO-2025)
  • 26 Feb 2025 Discontinued - Phase-I for Solid tumours (Inoperable/Unresectable, Metastatic disease, Recurrent, Second-line therapy or greater) in USA, Japan (PO) (Roche pipeline, February 2025)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top